Elanco Reports Q3 2026 results with revenue up 11%
Elanco Animal Health reported third quarter 2026 results demonstrating increased revenue and profitability, raising full-year 2026 guidance and achieving a 2.9x net leverage ratio milestone.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed